Osmotic demyelination syndrome a rare complication of hyponatremia

Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-05-06 02:45 GMT   |   Update On 2023-05-06 08:57 GMT

Canada: A new study published in NEJM: Evidence has found that rapid correction of serum sodium is a common occurrence in patients with hyponatremia, but osmotic demyelination syndrome (ODS) is rare.

Hyponatremia is a condition in which there is a low level of sodium in the blood. Osmotic demyelination syndrome (ODS) is a rare but potentially devastating neurologic complication of hyponatremia that can lead to severe disability or death. The objective of this study was to determine the percentage of patients who developed ODS after being brought to the hospital with hyponatremia.

The study included 22,858 participants and was conducted by researchers at five academic hospitals in Toronto, Canada, and included a large, contemporary, multicenter cohort of patients admitted to the hospital with hyponatremia. The participants included in the study were adults with serum sodium levels less than 130mmol/L.

The following key takeaways were revealed by the study:

1. The mean initial serum sodium was 125 mmol/l, 11.9% of patients had serum sodium from 110 to 119 mmol/l and 1.2% had serum sodium less than 110 mmol/l.

2. Rapid correction of serum sodium occurred in 3632 (17.7%) admissions.

3. Twelve patients developed ODS (0.05%)

4. Seven (58%) patients who developed ODS did not have rapid correction of serum sodium.

The study concludes that although rapid correction of serum sodium is common in patients with hyponatremia, Osmotic demyelination syndrome (ODS) is a rare complication.

“However, more studies with a higher number of patients with ODS are needed to better understand potential causal factors for ODS. This study is a valuable contribution to the understanding of hyponatremia and its potential complications.” added the researchers of the study.

Reference:

MacMillan T., Shin S., Topf J., Kwan J., Weinerman A., et al.; Osmotic Demyelination Syndrome in Patients Hospitalized with Hyponatremia; NEJM Evid 2023;2(4) VOL. 2 NO. 4; doi: 10.1056/EVIDoa2200215

Tags:    
Article Source :  NEJM: Evidence

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News